[Translation] Tolerability and pharmacokinetics of single-center, open-label, dose-escalating recombinant human interleukin-1 receptor antagonist eye drops (rhIL-1Ra) in healthy volunteers
探索rhIL-1Ra滴眼液在健康志愿者中单次给药的安全可耐受剂量范围以及药代动力学,推荐用于Ib-IIa期临床试验的合理剂量。
[Translation] To explore the safe tolerable dose range and pharmacokinetics of rhIL-1Ra eye drops in healthy volunteers for a single administration, and recommend a reasonable dose for phase Ib-IIa clinical trials.